Activation AMPK in Hypothalamic Paraventricular Nucleus Improves Renovascular Hypertension Through ERK1/2-NF-κB Pathway
Cardiovascular Toxicology · 2024
DOI: 10.1007/s12012-024-09888-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Toxicology, 2024. Verfasst von Li-Yan Fu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center; Institute of Cardiov…. Hauptthemen laut MEDLINE: Paraventricular Hypothalamic Nucleus, Hypertension, Renovascular, AMP-Activated Protein Kinases, Disease Models, Animal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Research Program of Xi'an Children's Hospital, National Natural Science Foundation of China, Research Program of Xi’an Children’s Hospital.
Abstract (Originalsprache)
Hypertension is a globally prevalent disease, but the pathogenesis remains largely unclear. AMP-activated protein kinase (AMPK) is a nutrition-sensitive signal of cellular energy metabolism, which has a certain influence on the development of hypertension. Previously, we found a down-regulation of the phosphorylated (p-) form of AMPK, and the up-regulation of the angiotensin II type 1 receptor (AT1-R) and that of p-ERK1/2 in the hypothalamic paraventricular nucleus (PVN) of hypertensive rats. However, the exact mechanism underlying the relationship between AMPK and AT1-R in the PVN during hypertension remains unclear. Thus, we hypothesized that AMPK modulates AT1-R through the ERK1/2-NF-κB pathway in the PVN, thereby inhibiting sympathetic nerve activity and improving hypertension. To examine this hypothesis, we employed a renovascular hypertensive animal model developed via two-kidney, one-clip (2K1C) and sham-operated (SHAM). Artificial cerebrospinal fluid (aCSF), used as vehicle, or 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR, an AMPK activator, 60 μg/day) was microinjected bilaterally in the PVN of these rats for 4 weeks. In 2K1C rats, there an increase in systolic blood pressure (SBP) and circulating norepinephrine (NE). Also, the hypertensive rats had lowered expression of p-AMPK and p-AMPK/AMPK, elevated expression of p-ERK1/2, p-ERK1/2/ERK1/2 and AT1-R, increased NF-κB p65 activity in the PVN compared with the levels of these biomarkers in SHAM rats. Four weeks of bilateral PVN injection of AMPK activator AICAR, attenuated the NE level and SBP, increased the expression of p-AMPK and p-AMPK/AMPK, lessened the NF-κB p65 activity, decreased the expression of p-ERK1/2, p-ERK1/2/ERK1/2 and AT1-R in the PVN of 2K1C rats. Data from this study imply that the activation of AMPK within the PVN suppressed AT1-R expression through inhibiting the ERK1/2-NF-κB pathway, decreased the activity of the sympathetic nervous system, improved hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center; Institute of Cardiovascular Sciences, Translational Medicine Institute, Xi'an Jiaotong Uni…
- Basic Medical College, Jiamusi University, Jiamusi, 154007, Heilongjiang, China.
- Department of Infectious Diseases, The Second Affiliated Hospital, Air Force Military Medical University, Xi'an, 710038, Shaanxi, China.
- Department of Diagnosis, Shaanxi University of Chinese Medicine, Xi'an, 712046, Shaanxi, China.
- Institute of Pediatric Diseases, Xi'an Children's Hospital, Xi'an, 710002, Shaanxi, China.
Förderung
- Research Program of Xi'an Children's Hospital
- National Natural Science Foundation of China
- Research Program of Xi’an Children’s Hospital
Zitieren
APA
Fu, L. Y., Yang, Y., Li, R. J., Issotina Zibrila, A., Tian, H., Jia, X. Y., Qiao, J. A., Wu, J. M., Qi, J., Yu, X. J., & Kang, Y. M. (2024). Activation AMPK in Hypothalamic Paraventricular Nucleus Improves Renovascular Hypertension Through ERK1/2-NF-κB Pathway. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-024-09888-9
Vancouver
Fu LY, Yang Y, Li RJ, Issotina Zibrila A, Tian H, Jia XY, et al. Activation AMPK in Hypothalamic Paraventricular Nucleus Improves Renovascular Hypertension Through ERK1/2-NF-κB Pathway. Cardiovascular Toxicology. 2024. doi:10.1007/s12012-024-09888-9
BibTeX
@article{Fu2024,
author = {Fu, Li-Yan and Yang, Yu and Li, Rui-Juan and Issotina Zibrila, Abdoulaye and Tian, Hua and Jia, Xiu-Yue and Qiao, Jin-An and Wu, Jin-Min and Qi, Jie and Yu, Xiao-Jing and Kang, Yu-Ming},
title = {Activation AMPK in Hypothalamic Paraventricular Nucleus Improves Renovascular Hypertension Through ERK1/2-NF-κB Pathway},
journal = {Cardiovascular Toxicology},
year = {2024},
doi = {10.1007/s12012-024-09888-9}
}
EUVIMED